News
This acquisition enables ESTEVE CDMO (Esteve Química) to expand its contract development and manufacturing services for small ...
Burnley defender Maxime Esteve has signed a new five-year contract at the club. The 23-year-old has only been at the club ...
Burnley's exodus of their key players has continued with Maxime Esteve reacting emotionally after yet another exit was ...
Maxime Esteve Commits Future to Burnley with Long-Term DealBurnley have secured a key piece of business ahead of their ...
Esteve CDMO (Esteve Química) - part of privately-held Spanish drugmaker Lab Esteve - has acquired Regis Technologies, a ...
Burnley FC centre-back Maxime Estève (23) has signed a contract extension with the promoted Premier League side, according to ...
13h
Burnley Express on MSNMaxime Esteve makes big claim about his Burnley future after agreeing new contractMaxime Esteve says he hopes to remain a Burnley player for a “long time” after putting pen to paper on another new deal.
ESTEVE has entered into an agreement with Sanofi to acquire Caprelsa® (vandetanib) rights in more than 50 countries, a treatment that is used in adults and children above 5 years of age to treat ...
However, the same outlet has now reported that Esteve has signed a contract extension with the newly-promoted Premier League ...
ESTEVE acquires Regis Technologies, a United States-based Contract Development and Manufacturing Organization (CDMO), ...
This strategic move allows ESTEVE CDMO (actively operating under the Esteve Química brand) a physical presence in the United States, expanding its contract development and manufacturing solutions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results